We are live on ! Find out more
ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

79 hedge funds and large institutions have $64.8M invested in Zynerba Pharmaceuticals, Inc in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 17 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 17

6% less funds holding

Funds holding: 84 → 79 (-5)

18% less capital invested

Capital invested by funds: $79.1M → $64.8M (-$14.3M)

25% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 20

36% less call options, than puts

Call options by funds: $3.82M | Put options by funds: $5.95M

Holders
79
Holders Change
-5
Holders Change %
-5.95%
% of All Funds
1.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
29
Reduced
17
Closed
20
Calls
$3.82M
Puts
$5.95M
Net Calls
-$2.13M
Net Calls Change
-$2.08M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$2.07M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.82M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.28M
4
Bank of America
Bank of America
North Carolina
+$1.26M
5
Deutsche Bank
Deutsche Bank
Germany
+$599K

Top Sellers

Rank Fund Capital Flow
1
EMG
ETF Managers Group
New Jersey
-$4.4M
2
PCM
Portolan Capital Management
Massachusetts
-$2.33M
3
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$1.65M
4
ARTA
A.R.T. Advisors
New York
-$486K
5
LPL Financial
LPL Financial
California
-$351K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$310K +$71.8K +10,494 +26%
AllianceBernstein
27
AllianceBernstein
Tennessee
$276K – – –
HighTower Advisors
28
HighTower Advisors
Illinois
$265K -$171 -25 -0.1%
DTL
29
Dynamic Technology Lab
Singapore
$258K +$293K +42,782 New
UBS Group
30
UBS Group
Switzerland
$227K +$18.1K +2,642 +8%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$215K – – –
CSS
32
Cubist Systematic Strategies
Connecticut
$173K +$120K +17,615 +159%
AC
33
Aristides Capital
Kentucky
$160K +$181K +26,518 New
BWP
34
Bernardo Wealth Planning
Pennsylvania
$159K – – –
AQR Capital Management
35
AQR Capital Management
Connecticut
$149K +$71.1K +10,395 +73%
Wells Fargo
36
Wells Fargo
California
$147K +$55.1K +8,058 +49%
Barclays
37
Barclays
United Kingdom
$140K +$38.9K +5,685 +32%
GCP
38
GSA Capital Partners
United Kingdom
$134K +$151K +22,106 New
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$130K +$4.27K +624 +3%
PCM
40
Penserra Capital Management
California
$125K +$43.8K +6,402 +34%
Commonwealth Equity Services
41
Commonwealth Equity Services
Massachusetts
$113K +$4.79K +700 +4%
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$109K +$124K +18,100 New
Squarepoint
43
Squarepoint
New York
$104K +$36.6K +5,345 +45%
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$88K +$2.92K +427 +3%
AIG
45
American International Group
New York
$87K -$821 -120 -0.8%
ECM
46
ExodusPoint Capital Management
New York
$80K +$90.9K +13,290 New
Goldman Sachs
47
Goldman Sachs
New York
$76K -$10.2K -1,486 -11%
VOYA Investment Management
48
VOYA Investment Management
Georgia
$74K +$83.7K +12,238 New
Capital Fund Management (CFM)
49
Capital Fund Management (CFM)
France
$71K -$121K -17,725 -60%
CAN
50
Claraphi Advisory Network
United States
$70K -$21.1K -3,090 -21%
1
2
3 4

ZYNE Hedge Fund Activity: Q4 2019 in Review

79 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Zynerba Pharmaceuticals, Inc (ZYNE) for Q4 2019, worth a combined $64.8M — down 18% from $79.1M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ZYNE and 15 opened new positions — a net loss of 5 holders — while 17 trimmed existing stakes and 29 added.

The largest buyer was Morgan Stanley, adding an estimated $2.07M. The largest seller was ETF Managers Group, cutting an estimated $4.4M.

  • 79 institutional investors held Zynerba Pharmaceuticals, Inc (ZYNE) as of Q4 2019, down from 84 in Q3 2019.
  • Funds reported $64.8M of Zynerba Pharmaceuticals, Inc stock for Q4 2019, down 18% quarter-over-quarter.
  • 15 funds opened new Zynerba Pharmaceuticals, Inc positions in Q4 2019 and 20 closed out, a net change of -5 holders.
  • The largest Zynerba Pharmaceuticals, Inc buyer in Q4 2019 was Morgan Stanley, an estimated $2.07M added.
  • The largest Zynerba Pharmaceuticals, Inc seller in Q4 2019 was ETF Managers Group, an estimated $4.4M sold.

Based on aggregated 13F filings for Q4 2019.